These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 10902101)

  • 1. Cellular events linked to cardiac remodeling in heart failure: targets for pharmacologic intervention.
    Piano MR; Kim SD; Jarvis C
    J Cardiovasc Nurs; 2000 Jul; 14(4):1-23; quiz 119-20. PubMed ID: 10902101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathophysiology of chronic heart failure.
    Francis GS
    Am J Med; 2001 May; 110 Suppl 7A():37S-46S. PubMed ID: 11334774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasopeptidase inhibitors: potential role in the treatment of heart failure.
    Trindade PT; Rouleau JL
    Heart Fail Monit; 2001; 2(1):2-7. PubMed ID: 12634892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart failure: mechanisms of cardiac and vascular dysfunction and the rationale for pharmacologic intervention.
    Francis GS; Cohn JN
    FASEB J; 1990 Oct; 4(13):3068-75. PubMed ID: 2210153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced systolic heart failure: emerging pathophysiology and current management.
    Albert NM
    Prog Cardiovasc Nurs; 1998; 13(3):14-30. PubMed ID: 9950020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Review of the Molecular Mechanisms Underlying the Development and Progression of Cardiac Remodeling.
    Schirone L; Forte M; Palmerio S; Yee D; Nocella C; Angelini F; Pagano F; Schiavon S; Bordin A; Carrizzo A; Vecchione C; Valenti V; Chimenti I; De Falco E; Sciarretta S; Frati G
    Oxid Med Cell Longev; 2017; 2017():3920195. PubMed ID: 28751931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changing the remodeling process in heart failure: basic mechanisms and laboratory results.
    Francis GS
    Curr Opin Cardiol; 1998 May; 13(3):156-61. PubMed ID: 9649937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolving concepts in left ventricular systolic and diastolic remodeling: implications for therapy.
    Tang WH; Francis GS
    Curr Cardiol Rep; 2004 May; 6(3):200-4. PubMed ID: 15075056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New therapeutic strategies for heart failure: left ventricular remodeling as a target.
    Cohn JN
    J Card Fail; 2004 Dec; 10(6 Suppl):S200-1. PubMed ID: 15803550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart failure: novel therapeutic approaches.
    Patel C; Deoghare S
    J Postgrad Med; 2015; 61(2):101-8. PubMed ID: 25766342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging therapeutic targets in chronic heart failure: part II.
    Roenicke V; Leclair S; Hoffmann A; Becker M; Szado T; Kirsch T; Stoss O; Navé BT; Henkel T
    Expert Opin Ther Targets; 2003 Feb; 7(1):49-59. PubMed ID: 12556202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurohumoral activation and progression of heart failure: hypothetical and clinical considerations.
    Francis GS
    J Cardiovasc Pharmacol; 1998; 32 Suppl 1():S16-21. PubMed ID: 9731691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble guanylyl cyclase activation improves progressive cardiac remodeling and failure after myocardial infarction. Cardioprotection over ACE inhibition.
    Fraccarollo D; Galuppo P; Motschenbacher S; Ruetten H; Schäfer A; Bauersachs J
    Basic Res Cardiol; 2014 Jul; 109(4):421. PubMed ID: 24907870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute congestive heart failure: pharmacologic intervention.
    Kennedy GT
    Crit Care Nurs Clin North Am; 1992 Jun; 4(2):365-75. PubMed ID: 1599659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis of ventricular remodeling: role of the myocyte.
    Li F; Wang X; Yi XP; Gerdes AM
    Curr Heart Fail Rep; 2004; 1(1):5-8. PubMed ID: 16036018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormones, drugs, remodeling and outcome in heart failure and after myocardial infarction.
    Cohn JN
    Cardiovasc Drugs Ther; 2001 Jan; 15(1):9-10. PubMed ID: 11504169
    [No Abstract]   [Full Text] [Related]  

  • 17. Relation between left ventricular remodeling and clinical outcomes in heart failure patients with left ventricular systolic dysfunction.
    Udelson JE; Konstam MA
    J Card Fail; 2002 Dec; 8(6 Suppl):S465-71. PubMed ID: 12555159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left ventricular remodeling in heart failure: current concepts in clinical significance and assessment.
    Konstam MA; Kramer DG; Patel AR; Maron MS; Udelson JE
    JACC Cardiovasc Imaging; 2011 Jan; 4(1):98-108. PubMed ID: 21232712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptosis in heart failure.
    Sabbah HN; Sharov VG
    Prog Cardiovasc Dis; 1998; 40(6):549-62. PubMed ID: 9647609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cardiac remodeling in chronic heart failure].
    Kai H
    Nihon Rinsho; 2006 May; 64(5):855-60. PubMed ID: 16689365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.